Galli, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.081
AS - Asia 1.606
EU - Europa 1.107
SA - Sud America 305
AF - Africa 31
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.147
Nazione #
US - Stati Uniti d'America 2.044
CN - Cina 544
SG - Singapore 484
IT - Italia 437
BR - Brasile 244
HK - Hong Kong 240
GB - Regno Unito 162
VN - Vietnam 156
SE - Svezia 121
RU - Federazione Russa 93
DE - Germania 76
KR - Corea 46
FR - Francia 40
FI - Finlandia 33
ID - Indonesia 33
NL - Olanda 30
AR - Argentina 28
AT - Austria 26
MX - Messico 19
BG - Bulgaria 18
JP - Giappone 18
AU - Australia 16
TR - Turchia 16
MA - Marocco 13
CA - Canada 12
LT - Lituania 12
IQ - Iraq 11
BD - Bangladesh 10
EC - Ecuador 10
IN - India 9
PL - Polonia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
IE - Irlanda 7
ZA - Sudafrica 7
ES - Italia 6
HU - Ungheria 6
IL - Israele 5
KG - Kirghizistan 5
PT - Portogallo 5
UA - Ucraina 5
CL - Cile 4
EG - Egitto 4
GR - Grecia 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
BE - Belgio 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IR - Iran 3
PE - Perù 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GY - Guiana 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.147
Città #
Santa Clara 467
Singapore 295
Hefei 238
Hong Kong 238
Ashburn 214
Chandler 150
Fairfield 145
London 93
Nyköping 82
Beijing 73
Ho Chi Minh City 61
Milan 53
Moscow 49
Dallas 47
New York 46
Los Angeles 45
Seattle 45
Seoul 44
Wilmington 44
Cambridge 41
Woodbridge 37
Houston 36
Bologna 32
Chicago 32
Jakarta 27
Shanghai 27
Hanoi 26
Rome 24
Buffalo 23
Princeton 23
San Diego 22
Helsinki 21
Munich 20
Modena 19
São Paulo 19
Nuremberg 18
Sofia 17
The Dalles 17
Ann Arbor 16
Florence 16
Kent 15
Salt Lake City 15
Southend 14
Atlanta 12
Redondo Beach 12
Reggio Emilia 12
Parma 11
Lauterbourg 10
Portsmouth 10
Tokyo 10
Elk Grove Village 9
Louisville 9
Melbourne 9
Orem 9
Rio de Janeiro 9
Vienna 9
Ankara 8
Bremen 8
Brooklyn 8
Council Bluffs 8
Des Moines 8
Haiphong 8
Lappeenranta 8
Mexico City 8
Casablanca 7
Dearborn 7
Dublin 7
Frankfurt am Main 7
Padova 7
Porto Alegre 7
Warsaw 7
Biên Hòa 6
Boardman 6
Brasília 6
Columbus 6
Naples 6
Tampa 6
Trieste 6
Bari 5
Caivano 5
Da Nang 5
Kilburn 5
Montreal 5
Salvador 5
Thái Bình 5
Treviso 5
Zhengzhou 5
Amsterdam 4
Bishkek 4
Brindisi 4
Budapest 4
Bunbury 4
Cagliari 4
Catania 4
Chennai 4
Credaro 4
Denver 4
Düsseldorf 4
Guayaquil 4
Huskvarna 4
Totale 3.369
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 280
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 256
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 245
EULAR guidelines on ANCA-associated vasculitis in the real life 230
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 203
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 186
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 177
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 172
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 158
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 145
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 143
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 141
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 135
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 134
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 130
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 127
The management of large vessel vasculitides 127
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 125
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 124
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 115
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 115
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 115
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 114
Development of the Takayasu Arteritis Integrated Disease Activity Index 111
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 110
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 107
What to Know About Biopsy Sampling and Pathology in Vasculitis? 102
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 101
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 99
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 98
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 97
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 97
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 93
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 92
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 91
Current management of giant cell arteritis and its complications 85
Reply 83
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 83
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 59
Totale 5.205
Categoria #
all - tutte 25.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 7 4 10 21 18 27 22
2021/2022435 34 18 44 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20261.691 264 188 295 401 357 186 0 0 0 0 0 0
Totale 5.205